TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - GSK PLC Share Price

Certificat

DE000SN57HT5

Market Closed - Bid/Ask 01:37:25 03/05/2024 pm IST After market 01:17:06 am
6.7 EUR +7.37% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - GSK PLC 6.71 +0.15%
Current month+6.85%
1 month+4.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart GSK PLC
Chart TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - GSK PLC
Date Price Change Volume
03/24/03 6.7 +7.37% 0
02/24/02 6.24 +6.85% 0
30/24/30 5.84 +1.57% 0
29/24/29 5.75 +2.68% 0
26/24/26 5.6 +1.08% 0

Delayed Quote Börse Stuttgart

Last update May 03, 2024 at 01:37 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying GSK PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SN57HT
ISINDE000SN57HT5
Date issued 11/08/2022
Strike 1,171 p
Maturity Unlimited
Parity 1 : 1
Emission price 4.05
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.7
Lowest since issue 2.24
Spread 0.18
Spread %2.65%

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
17.34 GBP
Average target price
20.2 GBP
Spread / Average Target
+16.50%
Consensus